FDA Adverse Event Malfunction Summary report: N

ARCHITECT IPTH

MDR report key: 3240279 · Received July 22, 2013

Report

Report Number
1415939-2013-00298
Event Type
Malfunction
Date Received
July 22, 2013
Date of Event
July 9, 2013
Report Date
July 16, 2013
Manufacturer
ABBOTT GERMANY
Product Code
CEW
PMA / PMN Number
K063232
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ACCURACY TESTING WAS PERFORMED ACROSS THREE ARCHITECT ANALYZERS USING RETAINED KITS OF ARCHITECT PTH ASSAY LOT 00212K000. THREE LEVELS OF THE PTH ANALYTE WERE ANALYZED ON EACH INSTRUMENT. ALL RESULTS MET ACCEPTANCE CRITERIA INDICATING THAT REAGENT LOT IS PERFORMING ACCEPTABLY. A REVIEW OF COMPLAINT TRACKING AND TRENDING METRICS WAS PERFORMED AND IDENTIFIED NO ADVERSE TRENDS IN CONJUNCTION WITH THE COMPLAINT ISSUE CURRENTLY UNDER EVALUATION. THE ARCHITECT PTH ASSAY PACKAGE INSERT CONTAINS INFORMATION TO ADDRESS THE CURRENT CUSTOMER ISSUE. BASED ON THE RESULTS OF THE CURRENT EVALUATION, IT WAS CONCLUDED THAT THE ARCHITECT INTACT PTH ASSAY IS PERFORMING AS INTENDED. A PRODUCT MALFUNCTION WAS NOT IDENTIFIED. MANUFACTURER WAS INCORRECT IN THE INITIAL MDR SUBMISSION. CORRECT MANUFACTURER IS ABBOTT (B)(4). CONCOMITANT PRODUCT LIST NUMBER WAS INCORRECT IN THE INITIAL MDR SUBMISSION. THE CORRECT LIST NUMBER FOR THE ARCHITECT I2000SR ANALYZER IS LN: 03M74-02. MANUFACTURING SITE FOR DEVICE WAS INCORRECT IN THE INITIAL MDR SUBMISSION. THE CORRECT MANUFACTURING SITE FOR THE DEVICE IS ABBOTT (B)(4). (B)(4)

Additional Manufacturer Narrative · 1

AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. (B)(4).

Description of Event or Problem · 1

A PHYSICIAN QUESTIONED HIS OWN FALSELY DECREASED ARCHITECT IPTH ASSAY RESULT OF 20 PG/ML GENERATED ON AN ARCHITECT I2000SR ANALYZER. THE SAMPLE WAS STORED FROZEN AFTER TESTING. THE PHYSICIAN STATED THAT HIS LAST PTH RESULT OF 120 PG/ML WAS GENERATED AT A DIFFERENT FACILITY (METHODOLOGY UNKNOWN). THREE DAYS LATER, THE PRESENT SAMPLE WAS THAWED AND RECENTRIFUGED AND TESTED WITH A RESULT OF 91 PG/ML. THE CUSTOMER THEN RECHECKED SEVERAL OTHER IPTH SAMPLES FROM PREVIOUS DAYS' TESTING AND ALL CORRELATED WITH THEIR INITIAL RESULTS. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
339439 ARCHITECT IPTH CEW ABBOTT GERMANY 00212K000

Patients

Seq Age Sex Outcome Treatment
1 ARCHITECT I2000SR LN:03M74-02, SN: (B)(4)| ARCHITECT I2000SR LN:03M74-01, SN: (B)(4)